checkmate 650: nivolumab ipilimumab, ipilimumab alone, or cabazitaxel in mcrpc
Published 1 year ago • 84 plays • Length 0:50Download video MP4
Download video MP3
Similar videos
-
1:14
the implications of checkmate 650 for the clinical management of post-chemotherapy mcrpc
-
3:43
latest from checkmate 650: nivolumab plus ipilimumab for the treatment of metastatic castration-...
-
1:52
treatment sequencing in mcrpc: cabazitaxel vs. abiraterone or enzalutamide
-
3:59
checkmate 067 - combined nivolumab and ipilimumab
-
2:09
checkmate 032: nivolumab/ipilimumab for urothelial carcinoma
-
1:37
novel immunotherapeutic approaches under evaluation in patients with mcrpc
-
4:47
nivolumab chemotherapy combination treatment: checkmate649 and attraction-4
-
2:04
update on the checkmate649 trial in treatment-naïve gea
-
3:07
checkmate-214: nivolumab/ipilimumab for mrcc?
-
3:06
titan trial
-
1:13
prostate cancer trial
-
1:10
unmet needs in immunotherapy for prostate cancer
-
2:37
therap: cabazitaxel versus 177lu-psma-617 for mcrpc
-
1:12
the risk of concomitant prostate cancer in bladder cancer patients going for radical cystectomy
-
3:12
nivolumab for perioperative esophageal and gastroesophageal cancer: checkmate 577
-
8:41
mri-targeted biopsies and overdiagnosis in prostate cancer
-
2:41
mri advances, office biopsies, and bladder cancer treatment and staging | backtable urology clips
-
4:56
improving the prognosis for patients with mcrpc
-
2:33
dr. barocas on the ceasar trial in localized prostate cancer